Coronavirus Vaccine: Russia's second corona vaccine trial started, first human dose given

Read Time:1 Minute, 27 Second

Moscow, Reuters. A human trial of the second Corona vaccine has now begun in Coronavirus Vaccine, Russia. The RIA news agency reported on Tuesday that a Russian institute of virology has begun a trial for another corona vaccine. On July 27, under the human trial of the corona vaccine, the first dose of this corona vaccine has been given to one in five humans. The agency reported that the person felt fine after being given the vaccine dose. The RIA news agency quoted consumer protection watchdog Rospotrebnadzor as informing that another dose would be given to another human being on July 30 under the trial of Corona Vetsin by the Institute of Vector Virology Siberia.

According to the Clinical Trial Register, 100 people are expected to register for human trials. Those whose age will be between 187 and 60 years. According to the World Health Organization (WHO), the Institute of Vector Virology is working on six different potential corona vaccines. With this, work is progressing rapidly on the first Corona vaccine in Russia. The Gamalaya Institute, a research center in Moscow, completed an initial human trial of an adenovirus-based vaccine earlier this month. The company has said that it is preparing for a large-scale trial in August.

Efforts are on to stop the corona virus epidemic worldwide. According to the World Health Organization (WHO), more than 100 vaccine trials are underway worldwide. Four of these vaccines are in the third phase of human trials. Out of this, three Corona vaccines are being developed in China and one vaccine is undergoing trials in the UK.